Market Capitalization (Millions $) |
12,534 |
Shares
Outstanding (Millions) |
166 |
Employees |
22,000 |
Revenues (TTM) (Millions $) |
2,992 |
Net Income (TTM) (Millions $) |
548 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
138 |
Dr Reddy S Laboratories Limited
Dr. Reddy's Laboratories is one of the leading global pharmaceutical companies, headquartered in Hyderabad, India. The company was founded in 1984 and has since grown to become a global player in the pharmaceutical industry, with a presence in over 100 countries.
The company's primary focus is on developing and manufacturing generic drugs, biosimilars, and innovative pharmaceutical products. Dr. Reddy's product portfolio includes a wide range of therapeutic areas such as cardiovascular, oncology, neurology, dermatology, and gastroenterology.
One of the key strengths of Dr. Reddy's is its R&D capabilities. The company has a dedicated team of scientists and researchers who work on developing new drugs, improving formulations, and enhancing the efficiency of existing products. Dr. Reddy's has invested significantly in building state-of-the-art R&D facilities and collaborations with leading academic institutions and research organizations.
In addition to generic and biosimilar drugs, Dr. Reddy's also has a strong presence in the consumer health business through its subsidiary, Dr. Reddy's Laboratories, Inc. The company has a portfolio of OTC products such as pain relievers, cough and cold remedies, and digestive health supplements.
Dr. Reddy's has a global presence with manufacturing facilities in multiple countries, including India, the US, Mexico, and Russia. The company's sales and marketing activities are also spread across different geographies, with a significant focus on the US and Europe.
In recent years, Dr. Reddy's has made significant strides in creating a more sustainable business model, with a focus on reducing its carbon footprint, conserving energy, and developing eco-friendly products. The company is also committed to giving back to society, with initiatives such as providing free healthcare to underprivileged communities and supporting education programs.
Overall, Dr. Reddy's Laboratories is a well-established, innovative, and socially responsible organization that is poised for continued growth in the global pharmaceutical industry.
Company Address: 8-2-337 Hyderabad 500
Company Phone Number: 49002931 Stock Exchange / Ticker: NYSE RDY
RDY is expected to report next financial results on June 12, 2024. |
|
|